Pheochromocytoma: Clinical sciences

2,086views

Pheochromocytoma: Clinical sciences

Watch later

Watch later

Attention deficit hyperactivity disorder (ADHD): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Selective serotonin reuptake inhibitors
Atypical antidepressants
Monoamine oxidase inhibitors
Serotonin and norepinephrine reuptake inhibitors
Tricyclic antidepressants
Atypical antipsychotics
Typical antipsychotics
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Psychomotor stimulants
Malaria: Clinical sciences
Sickle cell disease: Clinical sciences
Multiple myeloma: Clinical sciences
Zika virus
Dengue virus
Human T-lymphotropic virus
Trichuris trichiura (Whipworm)
Ancylostoma duodenale and Necator americanus
Babesia
Plasmodium species (Malaria)
Diphyllobothrium latum
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Antimalarials
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Dyslipidemia: Clinical sciences
Congestive heart failure: Clinical sciences
Infectious endocarditis: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Deep vein thrombosis: Clinical sciences
Vasculitis: Pathology review
Adrenergic antagonists: Beta blockers
Calcium channel blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
ACE inhibitors, ARBs and direct renin inhibitors
Thiazide and thiazide-like diuretics
Lipid-lowering medications: Fibrates
Lipid-lowering medications: Statins
Miscellaneous lipid-lowering medications
Pheochromocytoma: Clinical sciences
Adrenal insufficiency: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Multiple endocrine neoplasia: Clinical sciences
Hyperparathyroidism: Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Hypopituitarism: Pathology review
Pituitary tumors: Pathology review
Hyperthyroidism: Pathology review
Hypothyroidism medications
Alcohol-induced hepatitis: Clinical sciences
Cirrhosis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Acute pancreatitis: Clinical sciences
Pilonidal disease: Clinical sciences
Hemorrhoids: Clinical sciences
Perianal abscess and fistula: Clinical sciences
Anal fissure: Clinical sciences
Appendicitis: Clinical sciences
Diverticulitis: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Gastritis: Clinical sciences
Peptic ulcer disease: Clinical sciences
Stress ulcers: Clinical sciences
Celiac disease: Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Infectious gastroenteritis: Clinical sciences
Esophageal cancer: Clinical sciences
Anal cancer: Clinical sciences
Colorectal cancer: Clinical sciences
Gastric cancer: Clinical sciences
Femoral hernias: Clinical sciences
Umbilical hernias: Clinical sciences
Inguinal hernias: Clinical sciences
Helicobacter pylori
Vibrio cholerae (Cholera)
Colorectal polyps and cancer: Pathology review
Acid reducing medications
Antidiarrheals
Hepatitis medications
Laxatives and cathartics
Well-patient care (adult): Clinical sciences
Well-patient care (GYN): Clinical sciences
Breast cancer screening: Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Skin cancer screening: Clinical sciences
Anaphylaxis: Clinical sciences
Glucocorticoids
Non-corticosteroid immunosuppressants and immunotherapies
Hemochromatosis: Clinical sciences
Henoch-Schonlein purpura: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Reactive arthritis: Clinical sciences
Temporal arteritis: Clinical sciences
Systemic sclerosis (scleroderma): Clinical sciences
Infectious mononucleosis: Clinical sciences
Lyme disease: Clinical sciences
Burns: Clinical sciences
Hypothermia: Clinical sciences
Yellow fever virus
Seronegative and septic arthritis: Pathology review
Water-soluble vitamin deficiency and toxicity: B1-B7: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review
Water-soluble vitamin deficiency and toxicity: B9, B12 and vitamin C: Pathology review
Zinc deficiency and protein-energy malnutrition: Pathology review
Environmental and chemical toxicities: Pathology review
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Azoles
Anthelmintic medications
Herpesvirus medications
Osteoporosis: Clinical sciences
Mechanical back pain: Clinical sciences
Gout: Clinical sciences
Calcium pyrophosphate deposition disease (pseudogout): Clinical sciences
Osteoarthritis: Clinical sciences
Inflammatory myopathies: Clinical sciences
Osteomyelitis: Clinical sciences
Septic arthritis: Clinical sciences
Compartment syndrome: Clinical sciences
Anatomy clinical correlates: Bones, joints and muscles of the back
Anatomy clinical correlates: Knee
Anatomy clinical correlates: Leg and ankle
Antigout medications
Osteoporosis medications
Subarachnoid hemorrhage: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Multiple sclerosis: Clinical sciences
Myasthenia gravis: Clinical sciences
West Nile virus
Adult brain tumors: Pathology review
Local anesthetics
Migraine medications
Adrenergic antagonists: Alpha blockers
Medications for neurodegenerative diseases
Preconception care: Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Asthma in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Estrogens and antiestrogens
Progestins and antiprogestins
Lower urinary tract infection: Clinical sciences
Pyelonephritis: Clinical sciences
Approach to acute kidney injury: Clinical sciences
Chronic kidney disease: Clinical sciences
Nephrolithiasis: Clinical sciences
BK virus (Hemorrhagic cystitis)
Fibroadenoma: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Breast papilloma: Clinical sciences
Infertility: Clinical sciences
Uterine leiomyoma: Clinical sciences
Perimenopause, menopause, and primary ovarian insufficiency: Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Testicular cancer: Clinical sciences
Benign breast conditions: Pathology review
Penile conditions: Pathology review
PDE5 inhibitors
Asthma: Clinical sciences
Sleep apnea: Clinical sciences
Coxiella burnetii (Q fever)
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Pulmonary corticosteroids and mast cell inhibitors
Benign skin lesions: Clinical sciences
Chest X-ray interpretation: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

A pheochromocytoma is a neuroendocrine tumor that develops from chromaffin cells. These cells are part of the sympathetic nervous system, so they secrete excessive catecholamines, such as norepinephrine and epinephrine, which causes severe hypertension.

The majority of pheochromocytomas develop in the adrenal gland; however, extra-adrenal pheochromocytomas, also called paragangliomas, can develop in other locations, such as the thorax, abdomen and pelvis.

Pheochromocytomas are commonly linked to genetic conditions like multiple endocrine neoplasia type 2, neurofibromatosis type 1, and Von Hippel-Lindau disease; but they can also occur sporadically in patients without a genetic condition.

Now, if your patient presents with chief concerns suggesting pheochromocytoma, you should first perform an ABCDE assessment to determine if they are unstable or stable.

If the patient is unstable, stabilize the airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry. Finally, if needed, provide supplemental oxygen.

Now here’s a high-yield fact! Patients with pheochromocytoma classically present with paroxysmal hypertension. When systolic blood pressure is above 180, or diastolic blood pressure is above 120 millimeters of mercury, that’s called a hypertensive crisis, which can lead to end-organ damage like heart failure, pulmonary edema, and intracranial hemorrhage.

So urgent treatment with an intravenous anti-hypertensive, such as nitroprusside, is essential. Keep in mind that blood pressure should be lowered gradually, over a 24-hour period, to avoid cerebral and myocardial hypoperfusion.

Alright, now that we're done with unstable patients, let’s go back to the ABCDE assessment and discuss the stable ones.

First, obtain a focused history and physical examination. Classically, patients with pheochromocytomas report episodes of severe hypertension associated with headaches, profuse sweating, and palpitations. They might also present with anxiety, chest pain, weakness, as well as nausea, and weight loss. Additionally, there might be a history of hypertension that has been unresponsive to antihypertensives.

On the flip side, physical exam findings typically include hypertension, which can be episodic or sustained, tachycardia, and orthostatic hypotension. Lastly, you may notice restlessness, tremor, and pallor. Of note, the physical exam in some patients can be normal outside hypertensive episodes.

Now, here’s a high-yield fact! The most common symptoms of pheochromocytoma can be remembered as the 5 Ps, which are increased blood Pressure; Pain, representing headache, Perspiration, Palpitations, and Pallor.

However, note that pheochromocytoma is known as the great masquerader, and it can present with isolated hypertension along with highly variable symptoms. So, always consider the possibility of pheochromocytoma in any patient with hypertension.

Alright, if you come across these findings, you should suspect pheochromocytoma.

Next, order labs, including 24 hour urine fractionated metanephrines or plasma free metanephrines. If metanephrines are not elevated, consider alternative diagnoses.

However, if metanephrines are elevated, proceed with imaging, such as a CT or MRI of the abdomen If imaging reveals no adrenal lesions, again, consider alternative diagnoses.

But, if imaging reveals a well-defined adrenal mass, you can diagnose pheochromocytoma.

Now here’s a clinical pearl to keep in mind! Pheochromocytomas follow the "rule of 10" where 10% are bilateral, so found in both adrenal glands; 10% occur in extra-adrenal areas; 10% are malignant, and 10% affect the pediatric population.

So, if metanephrine levels are elevated but no adrenal tumor is visible on the initial CT or MRI, consider imaging extra-adrenal locations. Also, note that you can use a PET scan to detect metastatic pheochromocytoma located in the lungs, liver, or bones.

Alright, now moving on to treatment!

The only treatment for pheochromocytoma is surgical removal, but preoperative management of hypertension is also important.

Typically, 10 to 14 days prior to surgery, you’ll start your patient on selective alpha 1 adrenergic blockers like prazosin, terazosin or doxazosin, or phenoxybenzamine.

Once you achieve adequate alpha-blockade, which usually takes around two days, you can start your patient on beta-blockers like metoprolol or propranolol to prevent reflex tachycardia.

Sources

  1. "The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma" Pancreas (2021)
  2. "Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline" J Clin Endocrinol Metab (2014)
  3. "Harrison’s Principles of Internal Medicine, 21st Edition" McGraw Hill Education (2022)